BRAF V600 MUTATION DETECTION
MRP - ₹ 6,200
What is a BRAF V600 MUTATION DETECTION?
The BRAF V600 Mutation Detection test is a molecular diagnostic test used to identify mutations in the BRAF gene, specifically at codon V600. This mutation leads to abnormal activation of the MAPK signaling pathway, driving uncontrolled cell growth in cancers such as melanoma, colorectal cancer, and thyroid cancer. Detecting the BRAF V600 mutation is crucial for guiding targeted therapy decisions, predicting prognosis, and selecting patients who may benefit from specific treatments like BRAF inhibitors or immunotherapy.
Additional Information
| Also known as/ Other names: | BRAF V600E Mutation Test, BRAF Mutation Analysis, BRAF Gene Mutation Detection, BRAF Molecular Testing |
| Parameters: | 1 |
| Recommended for: | M/F/Others |
| Sample Type: | FFPE Tissue block |
| Patient Preparation: | No prior preparation is needed |
| Reports: | 5 days |
FAQs
It helps healthcare profession targets therapy decisions, predict prognosis, and identify patients who may benefit from BRAF inhibitors or immunotherapy.
Patients with melanoma, colorectal cancer, thyroid cancer, or other tumors suspected of harboring BRAF mutations are recommended for testing.
A positive result indicates the presence of BRAF V600 mutation, guiding targeted therapy options.
It suggests no detectable BRAF V600 mutation in the tested tumor sample.
No, medications do not interfere with genetic mutation detection.
Yes, it is safe if clinically indicated, using tumor tissue samples.
Without testing, patients may miss opportunities for personalized treatment with targeted therapies.